Skip to main content
SpringerLink
Log in

Liver-directed therapies for patients with primary liver cancer and hepatic metastases

  • Published:
Current Treatment Options in Oncology Aims and scope Submit manuscript

Opinion statement

Liver cancer, whether primary or metastatic, is a major cause of death throughout the world. The surgical management of these diseases varies according to the extent of disease and the overall health of the patient. Surgical resection of hepatic disease remains the only chance for cure. However, a large proportion of patients with liver cancer are unable to undergo a complete surgical resection. These patients are often treated with liver-directed therapies. Although not as effective as surgical resection, these approaches can help to improve the survival of patients. In patients with primary liver cancer, underlying liver disease often prohibits surgical intervention. However, survival advantages have been gained with the application of percutaneous alcohol injection and radiofrequency ablation (RFA). In patients with hepatic metastases, the number of metastases is often what prevents surgical resection. In these patients, RFA, cryoablation, and hepatic artery infusional therapy have all aided in prolonging survival. As chemotherapeutic agents improve and targeted therapies are developed, more patients will be able to undergo surgical management of their liver cancer, primary or metastatic.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Thomas MB, Zhu AX: Hepatocellular carcinoma: the need for progress. J Clin Oncol 2005, 23:2892–2899.

    Article  PubMed  Google Scholar 

  2. Parkin DM, Pisani P, Ferlay J: Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999, 80:827–841.

    Article  PubMed  CAS  Google Scholar 

  3. Benson AB, Sigurdson ER, Arciero CA, et al.: NCCN Practice Guidelines in Oncology: Hepatobiliary Cancers. In National Comprehensive Cancer Network. Jenkintown, PA: 2006.

  4. Yamanaka N, Okamoto E, Toyosaka A, et al.: Prognostic factors after hepatectomy for hepatocellular carcinomas. A univariate and multivariate analysis. Cancer 1990, 65:1104–1110.

    Article  PubMed  CAS  Google Scholar 

  5. Parker GA, Lawrence W Jr, Horsley JS 3rd, et al.: Intraoperative ultrasound of the liver affects operative decision making. Ann Surg 1989, 209:569–576; discussion 576-577.

    Article  PubMed  CAS  Google Scholar 

  6. Zhou XD, Tang ZY, Yang BH, et al.: Experience of 1000 patients who underwent hepatectomy for small hepatocellular carcinoma. Cancer 2001, 91:1479–1486. Large experience with surgical resection for small hepatocellular carcinoma with outcomes.

    Article  PubMed  CAS  Google Scholar 

  7. Liu CL, Fan ST, Lo CM, et al.: Management of spontaneous rupture of hepatocellular carcinoma: single-center experience. J Clin Oncol 2001, 19:3725–3732.

    PubMed  CAS  Google Scholar 

  8. Bruix J, Castells A, Bosch J, et al.: Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology 1996, 111:1018–1022.

    Article  PubMed  CAS  Google Scholar 

  9. Makuuchi M, Sano K: The surgical approach to HCC: our progress and results in Japan. Liver Transpl 2004, 10:S46-S52.

    Article  PubMed  Google Scholar 

  10. Choi TK, Edward CS, Fan ST, et al.: Results of surgical resection for hepatocellular carcinoma. Hepatogastroenterology 1990, 37:172–175.

    PubMed  CAS  Google Scholar 

  11. Nagorney DM, van Heerden JA, Ilstrup DM, Adson MA: Primary hepatic malignancy: surgical management and determinants of survival. Surgery 1989, 106:740–748; discussion 748-749.

    PubMed  CAS  Google Scholar 

  12. Paquet KJ, Koussouris P, Mercado MA, et al.: Limited hepatic resection for selected cirrhotic patients with hepatocellular or cholangiocellular carcinoma: a prospective study. Br J Surg 1991, 78:459–462.

    Article  PubMed  CAS  Google Scholar 

  13. Ringe B, Pichlmayr R, Wittekind C, Tusch G: Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World J Surg 1991, 15:270–285.

    Article  PubMed  CAS  Google Scholar 

  14. Tsuzuki T, Ogata Y, Iida S, Shimazu M: Hepatic resection in 125 patients. Arch Surg 1984, 119:1025–1032.

    PubMed  CAS  Google Scholar 

  15. Chen MF, Jeng LB: Partial hepatic resection for hepatocellular carcinoma. J Gastroenterol Hepatol 1997, 12:S329-S334.

    PubMed  CAS  Google Scholar 

  16. Livraghi T, Giorgio A, Marin G, et al.: Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 1995, 197:101–108.

    PubMed  CAS  Google Scholar 

  17. Livraghi T, Benedini V, Lazzaroni S, et al.: Long term results of single session percutaneous ethanol injection in patients with large hepatocellular carcinoma. Cancer 1998, 83:48–57.

    Article  PubMed  CAS  Google Scholar 

  18. Arii S, Yamaoka Y, Futagawa S, et al.: Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology 2000, 32:1224–1229.

    Article  PubMed  CAS  Google Scholar 

  19. Livraghi T, Bolondi L, Lazzaroni S, et al.: Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. A study on 207 patients. Cancer 1992, 69:925–929.

    Article  PubMed  CAS  Google Scholar 

  20. Okuda K: Intratumor ethanol injection. J Surg Oncol Suppl 1993, 3:97–99.

    Article  PubMed  CAS  Google Scholar 

  21. Castells A, Bruix J, Bru C, et al.: Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection. Hepatology 1993, 18:1121–1126.

    PubMed  CAS  Google Scholar 

  22. Huang GT, Lee PH, Tsang YM, et al.: Percutaneous ethanol injection versus surgical resection for the treatment of small hepatocellular carcinoma: a prospective study. Ann Surg 2005, 242:36–42. Direct comparison of complete surgical resection versus PEI in the management of hepatocellular carcinoma.

    Article  PubMed  Google Scholar 

  23. Jansen MC, van Hillegersberg R, Chamuleau RA, et al.: Outcome of regional and local ablative therapies for hepatocellular carcinoma: a collective review. Eur J Surg Oncol 2005, 31:331–347.

    Article  PubMed  CAS  Google Scholar 

  24. Seifert JK, Junginger T, Morris DL: A collective review of the world literature on hepatic cryotherapy. J R Coll Surg Edinb 1998, 43:141–154.

    PubMed  CAS  Google Scholar 

  25. Pearson AS, Izzo F, Fleming RY, et al.: Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies. Am J Surg 1999, 178:592–599.

    Article  PubMed  CAS  Google Scholar 

  26. Zhou XD, Tang ZY: Cryotherapy for primary liver cancer. Semin Surg Oncol 1998, 14:171–174.

    Article  PubMed  CAS  Google Scholar 

  27. Curley SA, Izzo F, Ellis LM, et al.: Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg 2000, 232:381–391.

    Article  PubMed  CAS  Google Scholar 

  28. Livraghi T, Solbiati L, Meloni MF, et al.: Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 2003, 226:441–451.

    Article  PubMed  Google Scholar 

  29. de Baere T, Risse O, Kuoch V, et al.: Adverse events during radiofrequency treatment of 582 hepatic tumors. AJR Am J Roentgenol 2003, 181:695–700.

    PubMed  Google Scholar 

  30. Tateishi R, Shiina S, Teratani T, et al.: Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 2005, 103:1201–1209.

    Article  PubMed  Google Scholar 

  31. Barnett CC Jr, Curley SA: Ablative techniques for hepatocellular carcinoma. Semin Oncol 2001, 28:487–496.

    Article  PubMed  Google Scholar 

  32. Shiina S, Teratani T, Obi S, et al.: A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005, 129:122–130.

    Article  PubMed  Google Scholar 

  33. Lin SM, Lin CJ, Lin CC, et al.: Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 2005, 54:1151–1156. An examination of various nonresectional approaches to the treatment of hepatomas.

    Article  PubMed  CAS  Google Scholar 

  34. Colleoni M, Audisio RA, De Braud F, et al.: Practical considerations in the treatment of hepatocellular carcinoma. Drugs 1998, 55:367–382.

    Article  PubMed  CAS  Google Scholar 

  35. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire. N Engl J Med 1995, 332:1256–1261.

  36. Llovet JM, Bruix J: Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 2003, 37:429–442.

    Article  PubMed  CAS  Google Scholar 

  37. Popperl G, Helmberger T, Munzing W, et al.: Selective internal radiation therapy with SIR-Spheres in patients with nonresectable liver tumors. Cancer Biother Radiopharm 2005, 20:200–208.

    Article  PubMed  Google Scholar 

  38. Lim L, Gibbs P, Yip D, et al.: Prospective study of treatment with selective internal radiation therapy spheres in patients with unresectable primary or secondary hepatic malignancies. Intern Med J 2005, 35:222–227.

    Article  PubMed  CAS  Google Scholar 

  39. Carr BI: Hepatic arterial 90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients. Liver Transpl 2004, 10:S107-S110.

    Article  PubMed  Google Scholar 

  40. Scheele J, Stang R, Altendorf-Hofmann A, Paul M: Resection of colorectal liver metastases. World J Surg 1995, 19:59–71.

    Article  PubMed  CAS  Google Scholar 

  41. Adson MA, van Heerden JA, Adson MH, et al.: Resection of hepatic metastases from colorectal cancer. Arch Surg 1984, 119:647–651.

    PubMed  CAS  Google Scholar 

  42. Brown DA, Pommier RF, Woltering EA, Fletcher WS: Nonanatomic hepatic resection for secondary hepatic tumors with special reference to hemostatic technique. Arch Surg 1988, 123:1063–1066.

    PubMed  CAS  Google Scholar 

  43. Doci R, Gennari L, Bignami P, et al.: Morbidity and mortality after hepatic resection of metastases from colorectal cancer. Br J Surg 1995, 82:377–381.

    Article  PubMed  CAS  Google Scholar 

  44. Nordlinger B, Guiguet M, Vaillant JC, et al.: Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer 1996, 77:1254–1262.

    Article  PubMed  CAS  Google Scholar 

  45. Giacchetti S, Itzhaki M, Gruia G, et al.: Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol 1999, 10:663–669.

    Article  PubMed  CAS  Google Scholar 

  46. Bismuth H, Adam R: Reduction of nonresectable liver metastasis from colorectal cancer after oxaliplatin chemotherapy. Semin Oncol 1998, 25:40–46.

    PubMed  CAS  Google Scholar 

  47. Bismuth H, Adam R, Levi F, et al.: Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 1996, 224:509–520; discussion 520-522.

    Article  PubMed  CAS  Google Scholar 

  48. Fong Y, Fortner J, Sun RL, et al.: Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999, 230:309–318; discussion 318-321.

    Article  PubMed  CAS  Google Scholar 

  49. Hughes KS, Simon R, Songhorabodi S, et al.: Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. Surgery 1986, 100:278–284.

    PubMed  CAS  Google Scholar 

  50. Jamison RL, Donohue JH, Nagorney DM, et al.: Hepatic resection for metastatic colorectal cancer results in cure for some patients. Arch Surg 1997, 132:505–510; discussion 511.

    PubMed  CAS  Google Scholar 

  51. D'Angelica M, Brennan MF, Fortner JG, et al.: Ninety-six five-year survivors after liver resection for metastatic colorectal cancer. J Am Coll Surg 1997, 185:554–559.

    Article  PubMed  Google Scholar 

  52. Hughes KS, Rosenstein RB, Songhorabodi S, et al.: Resection of the liver for colorectal carcinoma metastases. A multi-institutional study of long-term survivors. Dis Colon Rectum 1988, 31:1–4.

    Article  PubMed  CAS  Google Scholar 

  53. Sotsky TK, Ravikumar TS: Cryotherapy in the treatment of liver metastases from colorectal cancer. Semin Oncol 2002, 29:183–191.

    Article  PubMed  Google Scholar 

  54. Seifert JK, Morris DL: Prognostic factors after cryotherapy for hepatic metastases from colorectal cancer. Ann Surg 1998, 228:201–208.

    Article  PubMed  CAS  Google Scholar 

  55. Weaver ML, Ashton JG, Zemel R: Treatment of colorectal liver metastases by cryotherapy. Semin Surg Oncol 1998, 14:163–170.

    Article  PubMed  CAS  Google Scholar 

  56. Wallace JR, Christians KK, Pitt HA, Quebbeman EJ: Cryotherapy extends the indications for treatment of colorectal liver metastases. Surgery 1999, 126:766–772; discussion 772-774.

    PubMed  CAS  Google Scholar 

  57. Scaife CL, Curley SA: Complication, local recurrence, and survival rates after radiofrequency ablation for hepatic malignancies. Surg Oncol Clin N Am 2003, 12:243–255.

    Article  PubMed  Google Scholar 

  58. Curley SA, Izzo F, Delrio P, et al.: Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg 1999, 230:1–8.

    Article  PubMed  CAS  Google Scholar 

  59. Iannitti DA, Dupuy DE, Mayo-Smith WW, Murphy B: Hepatic radiofrequency ablation. Arch Surg 2002, 137:422–426; discussion 427.

    Article  PubMed  Google Scholar 

  60. Durand-Zaleski I, Roche B, Buyse M, et al.: Economic implications of hepatic arterial infusion chemotherapy in treatment of nonresectable colorectal liver metastases. Meta-Analysis Group in Cancer. J Natl Cancer Inst 1997, 89:790–795.

    Article  PubMed  CAS  Google Scholar 

  61. Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. Meta-Analysis Group in Cancer. J Natl Cancer Inst 1996, 88:252–258.

  62. Harmantas A, Rotstein LE, Langer B: Regional versus systemic chemotherapy in the treatment of colorectal carcinoma metastatic to the liver. Is there a survival difference? Meta-analysis of the published literature. Cancer 1996, 78:1639–1645.

    Article  PubMed  CAS  Google Scholar 

  63. Kemeny NE, Niedzwiecki D, Hollis DR, et al.: Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). J Clin Oncol 2006, 24:1395–1403. Recent examination of the effectiveness of HAI in the treatment of colorectal cancer hepatic metastases.

    Article  PubMed  CAS  Google Scholar 

  64. Gray B, Van Hazel G, Hope M, et al.: Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. Ann Oncol 2001, 12:1711–1720.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgical Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, 19111, Philadelphia, PA, USA

    Elin R. Sigurdson MD, PhD

Authors
  1. Cletus A. Arciero MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elin R. Sigurdson MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Arciero, C.A., Sigurdson, E.R. Liver-directed therapies for patients with primary liver cancer and hepatic metastases. Curr. Treat. Options in Oncol. 7, 399–409 (2006). https://doi.org/10.1007/s11864-006-0008-7

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11864-006-0008-7

Keywords

Search

Navigation